# Phytolon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phytolon

- Industry: Food
- Headquarters: Yokneam Illit, Israel
- Website: www.phytolon.com
- Total disclosed funding: $38M
- Latest round: Series B (Apr 30, 2026)
- Investors on record: 10

## About

Based in Israel, Phytolon Ltd. specializes in developing innovative natural colors for the food industry, focusing on sustainability and performance across various applications such as dairy and plant-based products.Phytolon Ltd. was founded in 2018 in Yokneam Illit, Israel. The company develops natural food colorants using a fermentation-based method, ensuring a reliable supply independent of agricultural variations. Co-founded by Guy Polturak, Halim Jubran, and Tal Zeltzer, Halim Jubran currently serves as CEO.

In May 2026, Phytolon Ltd. raised USD 23.6 million in series B funding from Millennium Food-Tech, NextGen Nutrition Investment Partners and Colorcon Ventures. 

The company will use the May 2026 funding to expand global supply for consumer packaged goods and distribution partners, while driving its sales strategy.

## Funding rounds

- Series B, Apr 30, 2026, $24M — Colorcon Ventures, Millennium Food-Tech, NextGen Nutrition Investment Partners
- Series A, Jul 6, 2022, $15M — DSM Venturing, Trendlines Group, Ginkgo BioWorks, Inc., Arkin Capital, Agriline Ltd, Millennium Food-Tech, Stern Tech, Cibus Capital

## Investors

- DSM Venturing (https://capitalatlas.ai/funds/dsm-venturing) — Series A
- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Series A
- Ginkgo BioWorks, Inc. — Series A
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Series A
- Agriline Ltd — Series A
- Millennium Food-Tech — Series A, Series B
- Stern Tech — Series A
- Cibus Capital (https://capitalatlas.ai/funds/cibus-capital) — Series A
- Colorcon Ventures (https://capitalatlas.ai/funds/colorcon-ventures) — Series B
- NextGen Nutrition Investment Partners (https://capitalatlas.ai/funds/nextgen-nutrition-investment-partners) — Series B